|« Previous month||Next month »|
29-Feb-2012 - The US FDA has sent APP Pharmaceuticals a warning letter after insects were found in production areas and finished products.
29-Feb-2012 - Researchers are calling for alternative excipients for vegetarians who are unwittingly consuming animal fats when physicians prescribe meds containing gelatin.
29-Feb-2012 - Eli Lilly says plans for a new €330m ($444m) manufacturing facility in Ireland are in preparation for the launch of a range of its pipeline molecules.
28-Feb-2012 - Reduced-pain injection systems are the key to gaining regulatory approval for new products, according to BD.
28-Feb-2012 - Marketing applications for heparin should cover traceability from slaughterhouses and other details of sourcing porcine mucosa, the EMA said.
28-Feb-2012 - Ingredients manufacturer Rousselot has announced a price increase on its gelatine portfolio to balance out spiralling raw material costs.
28-Feb-2012 - Almost 30 per cent of biopharma companies have insourced previously outsourced work in the past year, a PwC survey of CEOs found.
27-Feb-2012 - in-PharmaTechnologist presents its weekly round-up of the latest appointments within the pharmaceutical industry, including news from Biomatters, Seattle Genetics, and Permeon.
27-Feb-2012 - API sales at Latvia-based Grindeks jumped last year as it benefited from expanding its portfolio by 50 per cent.
27-Feb-2012 - Glenmark is recalling incorrectly packaged birth control pills from the US, less than one month after Pfizer took similar actions.
27-Feb-2012 - Sole suppliers that outsource manufacture must alert the FDA of interruptions at their CMOs, the Agency wrote in draft drug shortages guidance.
27-Feb-2012 - The US FDA has published final guidance on the CMC data needed to support early phase trials of live biotherapeutics.
23-Feb-2012 - The US FDA has issued import alerts against 22 Chinese heparin suppliers it claims ship adulterated product.
23-Feb-2012 - IPEC Americas has issued an urgent call for drug industry feedback on China Pharmacopoeia Committee plans to expand the number of excipients listed in the 2015 edition of the Chinese Pharmacopoeia.
23-Feb-2012 - Unilife is expanding its large dose delivery platform in a bid to meet a “growing industry need” for at-home drug administration in bigger scale.
23-Feb-2012 - The US FDA has published draft guidance on drug shortages to clarify when and how manufacturers should report possible supply disruptions.
22-Feb-2012 - Freeman Technology says growing Pharma demand for analytical data prompted the formation of US subsidiary and it behind its plans for a new laboratory.
22-Feb-2012 - BASF has increased its European prices for ethanolamines (EOA) for the third time in as many months.
22-Feb-2012 - Bespak is on the hunt for more development contracts for its new nasal delivery platform.
22-Feb-2012 - The US FDA is allowing Sun Pharma to import a version of Doxil to ease the drug shortage created by manufacturing failings at Ben Venue.
21-Feb-2012 - GE Healthcare has launched a new suite of bioprocess training courses in collaboration with a leading Singapore academic institution.
21-Feb-2012 - Aptar Pharma says its new eDevices can help companies gain quicker regulatory approval for their nasal drug products without having to re-do clinical trials.
21-Feb-2012 - Abbott Laboratories will pump €85m ($113m) into the expansion of its API production plant in Sligo, Ireland, in preparation of the launch of its pipeline products.
21-Feb-2012 - Pfizer and Mylan have settled patent litigation with Sanofi over a pre-filled drug delivery device used to treat allergic reactions.
21-Feb-2012 - Regulators should consider the impact of job cuts at manufacturing sites when drafting a risk-based GMP inspection plan, PIC/S said.
|« Previous month||Next month »|